Nonsteroidal anti-inflammatory drugs in the treatment of pericarditis: Clinical review

Cardiology in Review

Volumn 11, Issue 4, 2003, Pages 211-217

  Schifferdecker, Branislav ^a   Spodick, David H ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; DIFLUNISAL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; MECLOFENAMATE SODIUM; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SALSALATE; TOLMETIN;

ANGIONEUROTIC EDEMA; ASEPTIC MENINGITIS; ASTHMA; CAPILLARY RESISTANCE; CHOLESTASIS; COLITIS; COMA; CONGESTIVE HEART FAILURE; CORONARY ARTERY CONSTRICTION; DIGESTIVE SYSTEM PERFORATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DYSPEPSIA; ESOPHAGITIS; GASTRITIS; GASTRODUODENAL ULCER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART INFARCTION; HEMOPTYSIS; HUMAN; HYPERKALEMIA; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; KIDNEY PAPILLA NECROSIS; LIVER DISEASE; LIVER FAILURE; PEPTIC ULCER BLEEDING; PERICARDITIS; PETECHIA; PHOTOSENSITIVITY DISORDER; PNEUMONIA; PSEUDOPORPHYRIA; PSYCHOSIS; REVIEW; RHINITIS; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TINNITUS; URTICARIA; VERTIGO;

EID: 0037778758     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CRD.0000077500.07781.C9     Document Type: Review

References (36)

1. Preston SJ, Arnold MH, Beller EM, et al.: Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis. Br J Clin Pharmacol 1989;27:607-611.
2. Bombardier C, Peloso PM, Goldsmith CH: Salsalate, a nonacetylated salicylate, is as efficacious as diclofenac in patients with rheumatoid arthritis. Salsalate-Diclofenac Study Group J Rheumatol 1995;22:617-624.
3. Brooks PM, Day RO: Nonsteroidal antiinflammatory drugs-differences and similarities. N Engl J Med 1991;324:1716-1725.
4. Fries JF, Spitz PW, Williams CA, et al.: A toxicity index for comparison of side effects among different drugs. Arthritis Rheum 1990;33:121-130.
5. Hammerman H, Kloner RA, Schoen FJ, et al.: Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation 1983;67:1290-1295.
6. Brown EJ, Kloner RA, Schoen FJ, et al.: Scar thinning due to ibuprofen administration after experimental myocardial infarction. Am J Cardiol 1983;51:877-883.
7. Alexander RW, Kent KM, Pisano JJ, et al.: Regulation of postocclusive hyperemia by endogenously synthesized prostaglandins in the dog heart. J Clin Invest 1975;55:1174.
8. Friedman PL, Brown EJ, Gunther S, et al.: Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. N Engl J Med 1981;305:1171.
9. Altman J, Dulas D, Bache RJ: Effect of cyclooxygenase blockade on blood flow through well-developed coronary collateral vessels. Circ Res 1992;70:1091-1098.
10. Pacold I, Hwang MH, Lawless CE, et al.: Effects of indomethacin on coronary hemodynamics, myocardial metabolism and anginal threshold in coronary artery disease. Am J Cardiol 1986;57:912-915,
11. Page J, Henry D: Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 2000;160:777-784.
12. Heerdink ER, Leufkens HG, Herings RM, et al.: NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998;158:1108-1112.
13. Guazzi M, Pontone G, Agostoni P: Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors. Am Heart J 1999;138:254-260.
14. Cleland JGF, Bulpitt CJ, Falk RH, et al.: Is aspirin safe for patients with heart failure? [Review]. Br Heart J 1995;74:215-219.
15. Pope JE, Anderson JJ, Felson DT: A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993;153:477-484.
16. Johnson AG, Nguyen TV, Day RO: Do nonsteroidal antiinflammatory drugs affect blood pressure? A meta-analysis [see comments] Ann Intern Med 1994;121:289-300.
17. Ruoff GE. The impact of nonsteroidal anti-inflammatory drugs on hypertension: alternative analgesics for patients at risk. Clin Ther 1998;20:376-387.
18. Tramer MR, Moore RA, Reynolds DJ, et al.: Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use. Pain 2000;85:169-182.
19. Polisson R: Nonsteroidal anti-inflammatory drugs: practical and theoretical considerations in their selection. Am J Med 1996;100(2A):31S-36S
20. Garcia Rodriguez LA, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994;343(8900):769-772.
21. Yeomans ND, Tulassay Z, Juhasz L, et al.: A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998;338:719-26.
22. Whelton A: Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999;106(5B):13S-24S
23. Bouland DL, Specht NL, Hegstad DR: Ibuprofen and aseptic meningitis [letter]. Ann Intern Med 1986;104:731.
24. Kruis R, Barger R: Paranoid psychosis with sulindac. JAMA 1980;243:1420.
25. Mandell BF: General tolerability and use of nonsteroidal anti-inflammatory drugs. Am J Med 1999;107(6A):72S-77S
26. Berman J, Haffajee CI, Alpert JS: Therapy of symptomatic pericarditis after myocardial infarction: retrospective and prospective studies of aspirin, indomethacin, prednisone, and spontaneous resolution. Am Heart J 1981;101:750-753.
27. Catella-Lawson F, Reilly MP, Kapoor SC, et al.: Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001;345:1809-1817.
28. Fowler NO, Harbin AD: Recurrent acute pericarditis: follow-up study of 31 patients. J Am Coll Cardiol 1986;7:300-305.
29. Adler Y, Finkelstein Y, Guindo J, et al.: Colchicine treatment for reccurent pericarditis: a decade of experience. Circulation 1998;97:2183-2185.
30. Sagrista-Sauleda J, Angel J, Permanyer-Miralda G, et al.: Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med 1999;341:2054-2059.
31. Adler Y, Guindo J, Finkelstein Y, et al.: Colchicine for large pericardial effusions. Clin Cardiol 1998;21:143-144.
32. Figueroa W, Alankar S, Pai N, et al.: Subxiphoid pericardial window for pericardial effusion in end-stage renal disease. Am J Kidney Dis 1996;27:664-667.
33. Gunukula SR. Spodick DH: Pericardial disease in renal patients. Semin Nephrol 2001;21:52-56.
34. Minuth ANW, Nottebohm GA, Eknoyan G, et al.: Indomethacin treatment of pericarditis in chronic hemodialysis patients. Arch Intern Med 1975;135:807-811.
35. Spodick DH: Pericardial involvement in diseases of the heart and other contiguous structures. In: Spodick DH, ed. The pericardium: A Comprehensive Textbook. New York: Marcel Dekker, 1997;334-367.
36. Maisch B, Ristic AD, Seferovic PM, et al.: Intrapericardial treatment of autoreactive myocarditis with triamcinolone. Successful administration in patients with minimal pericardial effusion. Herz 2000;25:781-786.